| Joint EFLM-COLABIOCLI Recommendation for venous blood sampling |
27 |
| Indirect methods for reference interval determination - review and recommendations |
26 |
| Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use |
26 |
| Telomere biology and age-related diseases |
18 |
| Practical recommendations for managing hemolyzed samples in clinical chemistry testing |
17 |
| Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome |
15 |
| Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects |
14 |
| The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants |
14 |
| Results of the first external quality assessment scheme (EQA) for isolation and analysis of circulating tumour DNA (ctDNA) |
14 |
| Liquid biopsy in ovarian cancer: recent advances on circulating tumor (c)ells and circulating tumor DNA |
14 |
| Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey |
14 |
| Is irisin the new player in exercise-induced adaptations or not? A 2017 update |
13 |
| Serum exosomal hnRNPH1 mRNA as a novel marker for hepatocellular carcinoma |
12 |
| Preanalytical challenges - time for solutions |
12 |
| Extracellular vesicle-associated miRNAs in ovarian cancer - design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistance |
12 |
| Procalcitonin-guided antibiotic therapy: an expert consensus |
12 |
| Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome |
12 |
| Long non-coding RNA-mediated regulation of signaling pathways in gastric cancer |
11 |
| High sensitivity, contemporary and point-of-care cardiac troponin assays: educational aids developed by the IFCC Committee on Clinical Application of Cardiac Bio-Markers |
10 |
| The EFLM strategy for harmonization of the preanalytical phase |
10 |
| Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study |
10 |
| Definition of the upper reference limit of glycated albumin in blood donors from Italy |
10 |
| Laboratory medicine: health evaluation in elite athletes |
10 |
| Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches |
10 |
| The use of error and uncertainty methods in the medical laboratory |
10 |
| Comparison of six commercial serum exosome isolation methods suitable for clinical laboratories. Effect in cytokine analysis |
9 |
| Design and implementation of quality control plans that integrate moving average and internal quality control: incorporating the best of both worlds |
9 |
| Hair testing of GHB: an everlasting issue in forensic toxicology |
9 |
| Danger of false negative (exclusion) or false positive (diagnosis) for 'congenital thrombophilia' in the age of anticoagulants |
9 |
| High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease |
9 |
| Determination of cannabinoids in oral fluid and urine of light cannabis consumers: a pilot study |
9 |
| Non-invasive prenatal diagnosis of paternally inherited disorders from maternal plasma: detection of NF1 and CFTR mutations using droplet digital PCR |
8 |
| Precision, accuracy, cross reactivity and comparability of serum indices measurement on Abbott Architect c Beckman Coulter AU5800 and Roche Cobas 6000 c501 clinical chemistry analyzers |
8 |
| Harmonization in laboratory medicine: more than clinical chemistry? |
8 |
| Strong impact on plasma protein profiles by precentrifugation delay but not by repeated freeze-thaw cycles, as analyzed using multiplex proximity extension assays |
8 |
| Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor |
8 |
| Linking type 2 diabetes and gynecological cancer: an introductory overview |
8 |
| Evaluating the diagnostic and prognostic value of serum long non-coding RNA CTC-497E21.4 in gastric cancer |
8 |
| A pilot study of new promising non-coding RNA diagnostic biomarkers for early-stage colorectal cancers |
8 |
| Effect of an activated charcoal product (DOAC Stop (TM)) intended for extracting DOACs on various other APTT-prolonging anticoagulants |
8 |
| Stability of routine biochemical analytes in whole blood and plasma/serum: focus on potassium stability from lithium heparin |
8 |
| Moving average quality control: principles, practical application and future perspectives |
8 |
| Digital transformation in healthcare - architectures of present and future information technologies |
8 |
| Personalized laboratory medicine: a patient-centered future approach |
7 |
| Reference interval by the indirect approach of serum thyrotropin (TSH) in a Mediterranean adult population and the association with age and gender |
7 |
| NGAL and MMP-9/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosis |
7 |
| Machine learning in laboratory medicine: waiting for the flood? |
7 |
| Neutrophil gelatinase-associated lipocalin as a risk marker in cardiovascular disease |
7 |
| Pediatric reference intervals for 25-dihydroxyvitamin D using the DiaSorin LIAISON XL assay in the healthy CALIPER cohort |
7 |
| Use of circulating tumor cells in prospective clinical trials for NSCLC patients - standardization of the pre-analytical conditions |
7 |
